Evidence map›Paper›PMID 18270205›Full record

ArticleThe Journal of biological chemistry2008

Structural basis for ubiquitin recognition by the Otu1 ovarian tumor domain protein.

Troy Eugene Messick, Nathaniel Scott Russell, Ayaka Jennifer Iwata, Kathryn Lorenz Sarachan, Ramin Shiekhattar, John R Shanks, Francisca E Reyes-Turcu, Keith D Wilkinson, Ronen Marmorstein

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Capturing the catalytic intermediates of parkin ubiquitination.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. The emerging role of Deubiquitinases (DUBs) in parasites: A foresight review.Frontiers in cellular and infection microbiology · 2022
    Review
  9. Ubiquitin-proteasome pathway annotation inGigaByte (Hong Kong, China) · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Troy Eugene MessickWistar Institute, Philadelphia, Pennsylvania 19104, USA.
Nathaniel Scott Russell
Ayaka Jennifer Iwata
Kathryn Lorenz Sarachan
Ramin Shiekhattar
John R Shanks
Francisca E Reyes-Turcu
Keith D Wilkinson
Ronen Marmorstein
Emory University · USThe Wistar Institute · USUniversity of Pennsylvania · US

Funding

STRUCTURAL BIOLOGY TRAINING PROGRAMT32GM008275 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI WAND, A. JOSHUA · 1988 to 2018
$6.0M
UBIQUITIN-DEPENDENT PROTEOLYSIS--SPECIFICITY/MECHANISMR01GM030308 · NIGMS · EMORY UNIVERSITY · PI WILKINSON, KEITH D · 1985 to 2010
$3.9M
NIGMS NIH HHS GM30308NIGMS NIH HHS T32 GM008275
6 · The paper itself

Abstract

Ubiquitination of proteins modifies protein function by either altering their activities, promoting their degradation, or altering their subcellular localization. Deubiquitinating enzymes are proteases that reverse this ubiquitination. Previous studies demonstrate that proteins that contain an ovarian tumor (OTU) domain possess deubiquitinating activity. This domain of approximately 130 amino acids is weakly similar to the papain family of proteases and is highly conserved from yeast to mammals. Here we report structural and functional studies on the OTU domain-containing protein from yeast, Otu1. We show that Otu1 binds polyubiquitin chain analogs more tightly than monoubiquitin and preferentially hydrolyzes longer polyubiquitin chains with Lys(48) linkages, having little or no activity on Lys(63)- and Lys(29)-linked chains. We also show that Otu1 interacts with Cdc48, a regulator of the ER-associated degradation pathway. We also report the x-ray crystal structure of the OTU domain of Otu1 covalently complexed with ubiquitin and carry out structure-guided mutagenesis revealing a novel mode of ubiquitin recognition and a variation on the papain protease catalytic site configuration that appears to be conserved within the OTU family of ubiquitin hydrolases. Together, these studies provide new insights into ubiquitin binding and hydrolysis by yeast Otu1 and other OTU domain-containing proteins.

Indexed as

Adenosine TriphosphatasesAmino Acid SequenceAnimalsCell Cycle ProteinsCysteine EndopeptidasesDose-Response Relationship, DrugFungal ProteinsHumansModels, BiologicalMolecular Sequence DataProtein BindingProtein Interaction MappingProtein Structure, TertiarySaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSequence Homology, Amino AcidAdenosine TriphosphatasesCDC48 protein, S cerevisiaeCell Cycle ProteinsCysteine EndopeptidasesFungal ProteinsOTUB2 protein, humanSaccharomyces cerevisiae ProteinsThiolester HydrolasesUbiquitinValosin Containing Protein

Identifiers

PMID18270205
PMCPMC2447653
OpenAlexW2070008395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.